title: Vitamin D in chronic kidney disease.
abstract: Vitamin D deficiency is widespread in both the pediatric and adult chronic kidney disease (CKD) population. CKD is characterized by dysregulation of vitamin D and mineral metabolism. Secondary hyperparathyroidism and its management puts patients with CKD at increased cardiovascular risk. Emergence of experimental and some clinical data suggesting beneficial effects of vitamin D on proteinuria, blood pressure, inflammation and cardiovascular outcomes has pushed it to the center stage of CKD research. Pediatric data on vitamin D dysregulation and its consequences are still in its infancy. Ongoing prospective studies such as Chronic Kidney disease in Children (CKiD) and the Cardiovascular Comorbidity in Children with CKD (4 C) should help to delineate the evolution of disturbances in mineral metabolism and its adverse effects on growth, CKD progression and cardiovascular outcomes.
authors.affiliation: Taipei Cathay General Hospital, Taipei, Taiwan.
authors.forename: Yahn-Yir
authors.initials: YY
authors.lastname: Chau
authors.forename: Juhi
authors.initials: J
authors.lastname: Kumar
mesh_terms: D002648:Child; D002762:Cholecalciferol / Q000494:pharmacology / Q000627:therapeutic use; D019587:Dietary Supplements; D004872:Ergocalciferols / Q000494:pharmacology / Q000627:therapeutic use; D006130:Growth Disorders / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000209:etiology / Q000517:prevention & control; D007668:Kidney / Q000187:drug effects; D051436:Renal Insufficiency, Chronic / Q000150:complications*; D014807:Vitamin D / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use; D014808:Vitamin D Deficiency / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D014815:Vitamins / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D004872:Ergocalciferols; D014815:Vitamins; D014807:Vitamin D; D002762:Cholecalciferol